Jiang Dawei, Chen Zixi, Du Hongli
School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China.
Department of Gerontology, ShenZhen Longhua District Central Hospital, Shenzhen, China.
Front Bioinform. 2025 Mar 11;5:1566174. doi: 10.3389/fbinf.2025.1566174. eCollection 2025.
Membrane permeability is a critical bottleneck in the development of cyclic peptide drugs. Experimental membrane permeability testing is costly, and precise prediction tools are scarce. In this study, we developed CPMP (https://github.com/panda1103/CPMP), a cyclic peptide membrane permeability prediction model based on the Molecular Attention Transformer (MAT) frame. The model demonstrated robust predictive performance, achieving determination coefficients ( ) of 0.67 for PAMPA permeability prediction, and values of 0.75, 0.62, and 0.73 for Caco-2, RRCK, and MDCK cell permeability predictions, respectively. Its performance outperforms traditional machine learning methods and graph-based neural network models. In ablation experiments, we validated the effectiveness of each component in the MAT architecture. Additionally, we analyzed the impact of data pre-training and cyclic peptide conformation optimization on model performance.
膜通透性是环肽药物开发中的一个关键瓶颈。实验性膜通透性测试成本高昂,且精确的预测工具稀缺。在本研究中,我们开发了CPMP(https://github.com/panda1103/CPMP),这是一种基于分子注意力变换器(MAT)框架的环肽膜通透性预测模型。该模型表现出强大的预测性能,在PAMPA通透性预测中,决定系数( )达到0.67,在Caco-2、RRCK和MDCK细胞通透性预测中, 值分别为0.75、0.62和0.73。其性能优于传统机器学习方法和基于图的神经网络模型。在消融实验中,我们验证了MAT架构中每个组件的有效性。此外,我们分析了数据预训练和环肽构象优化对模型性能的影响。